The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Characteristics of Sexual Dysfunction in Patients With Lung Cancer
Official Title: Characteristics of Sexual Dysfunction in Patients With Lung Cancer
Study ID: NCT06018376
Brief Summary: The general objective of this observational study is identify and describe the type, frequency, and severity of sexual dysfunction in patients with lung cancer and generate strategies for clinical management and oncological follow-up directed and based on the specific findings in this population. The recruitment will be carried out from July 2023 and will be carried out until December 2023, the analysis of the information will be carried out from January to March 2024.
Detailed Description: It is planned to develop a study with a larger number of patients with lung cancer, including the population of Spain and Latin American countries to obtain a sample of more diverse and heterogeneous characteristics, with clinical, cultural, and sociodemographic differences. This will make it possible to obtain better and greater data and therefore define the clinical and treatment factors significantly associated with DS in these individuals and obtain a more complete vision of the reality of the problem. The results of this research will make it possible to carry out interventions specifically directed at this population and to modify the oncological follow-up guidelines currently in force. Likewise, the information collected will serve as the basis for generating new protocols for a multidisciplinary approach, including the participation of psychology and specialists in urology, gynecology, and psychiatry. The general objective of this observational study is identify and describe the type, frequency, and severity of sexual dysfunction in patients with lung cancer and generate strategies for clinical management and oncological follow-up directed and based on the specific findings in this population. The recruitment will be carried out from July 2023 and will be carried out until December 2023, the analysis of the information will be carried out from January to March 2024.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Instituto Alexander Flemming, Buenos Aires, , Argentina
Oncomedica, IMAT, Montería, Monteria, Colombia
Clínica Universitaria Colombia, Bogotá, , Colombia
Clinica del Occidente, Cali, , Colombia
Hematooncologos SA, Cali, , Colombia
Clínica de Medellín, Medellín, , Colombia
ALIADAS Instituto Nacional de Enfermedades Neoplasicas, Surquillo, , Peru
Centro Hospitalar do Porto, Porto, , Portugal
Hospital General de Elche, Elche, Alicante, Spain
ICO Badalona, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
Hospital General de Granollers, Granollers, Barcelona, Spain
Hospital La Mancha Centro, Alcázar De San Juan, Ciudad Real, Spain
Hospitalario Universitario A Coruña, A Coruña, La Coruña, Spain
Hospital de Fuenlabrada, Fuenlabrada, Madrid, Spain
Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain
Hospital Infanta Sofia, San Sebastián De Los Reyes, Madrid, Spain
Hospital Universitario Cruces, Barakaldo, Vizcaya, Spain
Hospital Universitari Vall d' Hebron, Barcelona, , Spain
Hospital General Universitario de Ciudad Real, Ciudad Real, , Spain
Hospital Universitario Lucus Augusti, Lugo, , Spain
Hospital Clínico San Carlos, Madrid, , Spain
Hospital Universitario Fundación Jiménez Díaz, Madrid, , Spain
Hospital Universitari Son Llatzer, Palma De Mallorca, , Spain
Hospital Clínico de Salamanca, Salamanca, , Spain
Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz De Tenerife, , Spain
Xarxa sanitaria Santa Tecla- Tarragona, Tarragona, , Spain
Hospital General Universitario de Valencia, Valencia, , Spain
Hospital Universitario La Fe, Valencia, , Spain
Hospital Clínico Universitario de Valladolid, Valladolid, , Spain
Name: Aylen Vanessa Ospina Serrano, MD
Affiliation: Hospital Puerta del Hierro Investigator
Role: STUDY_CHAIR